Biomab EGFR 50mg Injection (Nimotuzumab) is a monoclonal antibody used to treat EGFR-expressing cancers, such as head and neck, brain (glioma), and sometimes lung or pancreatic cancers. It works by binding to cancer cells, marking them for immune system destruction and inhibiting growth. It is administered via IV infusion, typically alongside chemotherapy or radiation.